Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of High-fat Meal on Hetrombopag PK and Mass Balance
NCT02409394Phase 1Completed
- Sponsor
- Hengrui
- Start
- Mar 2014
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of hetrombopag in Thrombocytopenia (2 arms), sponsored by Hengrui. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve and 1 more. Started Mar 2014; status: completed.
02
Drugs
hetrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT02409394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02409394.